<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
13537-669-28
</NDCCode>
<PackageDescription>
2 TUBE in 1 BOX (13537-669-28) > 1 KIT in 1 TUBE (13537-669-27) * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE * 8 g in 1 TUBE
</PackageDescription>
<NDC11Code>
13537-0669-28
</NDC11Code>
<ProductNDC>
13537-669
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Esika Hydracolor 2 In 1 Spf 25
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Octinoxate And Oxybenzone
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20150825
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part352
</ApplicationNumber>
<LabelerName>
Ventura Corporation LTD
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>